Captopril
- Product NDC
- 63629-2541
- 11-digit product format
- 636292541
- Labeler code
- 63629
- Product ID
- 63629-2541_22d47bec-1025-49e8-9918-6451668ebc8d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Captopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA074532
- Marketing category
- ANDA
- Marketing start
- 2009-09-11
- Marketing end
- 0000-00-00
- Substance
- CAPTOPRIL
- Active strength
- 50 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63629-2541-1 | 2024-10-22 | C162847 | 48780-1 | 9855d018-dd75-cd31-e053-dbdaa90ab51a | c3c44e35-3d29-4b21-a4db-b101b4b3dca7 |
| 63629-2541-2 | 2024-10-22 | C162847 | 48780-1 | 9855d018-dd75-cd31-e053-dbdaa90ab51a | c3c44e35-3d29-4b21-a4db-b101b4b3dca7 |
| 63629-2541-3 | 2024-10-22 | C162847 | 48780-1 | 9855d018-dd75-cd31-e053-dbdaa90ab51a | c3c44e35-3d29-4b21-a4db-b101b4b3dca7 |
| 63629-2541-4 | 2024-10-22 | C162847 | 48780-1 | 9855d018-dd75-cd31-e053-dbdaa90ab51a | c3c44e35-3d29-4b21-a4db-b101b4b3dca7 |
| 63629-2541-1 | 2019-11-27 | C162847 | 48780-1 | 9855d018-dd75-cd31-e053-dbdaa90ab51a | c3c44e35-3d29-4b21-a4db-b101b4b3dca7 |
| 63629-2541-2 | 2019-11-27 | C162847 | 48780-1 | 9855d018-dd75-cd31-e053-dbdaa90ab51a | c3c44e35-3d29-4b21-a4db-b101b4b3dca7 |
| 63629-2541-3 | 2019-11-27 | C162847 | 48780-1 | 9855d018-dd75-cd31-e053-dbdaa90ab51a | c3c44e35-3d29-4b21-a4db-b101b4b3dca7 |
| 63629-2541-4 | 2019-11-27 | C162847 | 48780-1 | 9855d018-dd75-cd31-e053-dbdaa90ab51a | c3c44e35-3d29-4b21-a4db-b101b4b3dca7 |